Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lasers the Weapon of Choice in Fight Against Chronic Skin Diseases
  • USA - English


News provided by

MCPR, LLC

Aug 03, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Christopher Byrne, MPAS, RPA-C
Christopher Byrne, MPAS, RPA-C

Franklin Square, NY (PRWEB) August 03, 2017 -- “Let there be light!” The phrase has special meaning for dermatologists who are using technology that converts ultraviolet light into effective treatments for stubborn, chronic skin disorders, including psoriasis and vitiligo, said Christopher Byrne, RPA-C, certified physician assistant at Advanced Dermatology, P.C.

For some individuals, management and remission of their skin disease may require a combination of therapies, including phototherapy, oral and topical treatments, biological agents, surgical procedures -- even lifestyle changes.

Post this

Light therapy for skin disorders is not new. For example, ancient Egyptians combined heliotherapy (sunlight) with ingested extracts from a weed that grew in the Nile Delta to treat vitiligo, which causes splotchy white patches – patches of depigmentation -- to appear on the skin and can turn hair prematurely gray.

More recently, studies have confirmed the effectiveness of phototherapy in controlling and minimizing outbreaks of psoriasis and vitiligo – in particular, the use of excimer lasers, which send a narrow, concentrated band of light to disease-affected areas of the skin, Byrne said.

Although symptoms are different, both psoriasis and vitiligo are considered autoimmune diseases, with no known cure. They interrupt the body’s acquired immune system by causing antibodies and immune cells to attack, or interfere with, healthy tissue. In psoriasis, the autoimmune reaction triggers an overproduction of T-cells, resulting in development of plaques on the skin. T-cells are the body’s defense again invaders like bacteria and viruses. Vitiligo creates white skin patches by destroying the body’s melanocytes or pigment cells. Neither disease is life-threatening.

The International Federation of Psoriasis Associations reports that about 3 percent of the world’s population have some form of psoriasis. In the United States, approximately 150,000 new psoriasis cases are diagnosed every year. Even though vitiligo is listed as a “rare disease,” it affects about two million or more people in this country.

With an excimer laser, such as the hand-held Xtrac, dermatologists can break up the cells in the psoriasis plaques or darken the areas of skin affected by vitiligo, in some cases, achieving remission of the skin disorders for extended periods of time. This targeted light therapy is virtually painless, with few side effects like thinning or premature aging of skin. However, patients usually undergo multiple treatment sessions to achieve desired results, Byrne explained.

The federal Food and Drug Administration (FDA) approved use of the Xtrac laser in 2000 for treatment of mild and moderate cases of psoriasis. Since then, improvements in technology and protocols have shown the Xtrac and other excimer lasers capable of controlling vitiligo and serious cases of psoriasis, as well, Byrne said.

Some researchers caution that the jury is still out on whether phototherapy alone, or in combination with other treatments, is more effective than other approaches against these skin disorders. However, scientists writing in an online article, Recent advances in phototherapy for psoriasis, in July 2016, stated that “phototherapy remains a mainstay treatment [for psoriasis] with promise for further advancement.” A study appearing in JAMA Dermatology, in April 2017, indicated long-duration phototherapy is effective in treating vitiligo.
Although phototherapy is oftentimes the weapon of choice in treating psoriasis and vitiligo, researchers continue the hunt for even more advanced options.

The American Academy of Dermatology reported in early 2017 that a class of drugs – Janus kinase inhibitors (JAK) – shows promise in the management of immune-system-related skin problems, namely alopecia areata, eczema and vitiligo. The National Institutes of Health supports ongoing efforts to develop biologics that target cells and molecules involved in the regulation of the immune system.

“We have no magic pill yet for these chronic skin disorders,” Byrne said. “Doctors must assess each patient to determine the best treatment approach. For some individuals, management and remission of their skin disease may require a combination of therapies, including phototherapy, oral and topical treatments, biological agents, surgical procedures -- even lifestyle changes.”
Of course, sometimes the best defense is a good offense. That’s why Byrne offers this advice for controlling outbreaks of chronic skin problems:
• Stop smoking; limit consumption of alcohol. Both smoking and alcohol may aggravate skin disorders.
• Practice good nutrition. Although little research has been done on links between diet and skin condition, proper nutrition helps maintain a person’s overall health.
• Protect the skin from cuts, scrapes and the harmful effects of the sun’s rays. Insults to the skin invite flare-ups of disorders like psoriasis and vitiligo.
• Manage stress. Stress is known to aggravate a psoriatic condition, and evidence suggests that a particularly stressful event could be one trigger for vitiligo.
• Seek out support groups to learn how to cope with skin diseases that can cause feelings of embarrassment and contribute to mood disorders and depression.

Christopher Byrne RPA-C is a certified physician assistant

Advanced Dermatology, P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.

Melissa Chefec, MCPR, LLC, http://www.mcprpublicrelations.com, +1 (203) 968-6625, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.